EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    6.3.4.16 | Abscess |
28900609 |
Genes Contributing to Porphyromonas gingivalis Fitness in Abscess and Epithelial Cell Colonization Environments. |
ongoing research
unassigned |
2
0 |
| 6.3.4.16 | Adenocarcinoma |
19926579 |
Loss of carbamoyl phosphate synthetase I in small-intestinal adenocarcinoma. |
causal interaction
unassigned |
2
0 |
| 6.3.4.16 | Adenocarcinoma |
33868479 |
Expression profiling of CPS1 in Correa's cascade and its association with gastric cancer prognosis. |
ongoing research
unassigned |
1
0 |
| 6.3.4.16 | Adenocarcinoma of Lung |
9362155 |
Cigarette smoking and changes in the histopathology of lung cancer. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
2
2
0 |
| 6.3.4.16 | Alkalosis |
1600351 |
Metabolic alkalosis as driving force for urea synthesis in liver disease: pathogenetic model and therapeutic implications. |
unassigned |
0 |
| 6.3.4.16 | amino-acid n-acetyltransferase deficiency |
15164414 |
Genetic approach to prenatal diagnosis in urea cycle defects. |
causal interaction
unassigned |
4
0 |
| 6.3.4.16 | amino-acid n-acetyltransferase deficiency |
28888854 |
Quantitation of phenylbutyrate metabolites by UPLC-MS/MS demonstrates inverse correlation of phenylacetate:phenylacetylglutamine ratio with plasma glutamine levels. |
causal interaction
unassigned |
4
0 |
| 6.3.4.16 | amino-acid n-acetyltransferase deficiency |
31392111 |
N-carbamoylglutamate-responsive carbamoyl phosphate synthetase 1 (CPS1) deficiency: A patient with a novel CPS1 mutation and an experimental study on the mutation's effects. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 6.3.4.16 | amino-acid n-acetyltransferase deficiency |
32280145 |
ECMO as a Platform for Rapid Ammonia Removal in a Neonate with Multienzyme Urea Cycle Disorder. |
therapeutic application
unassigned |
1
0 |
| 6.3.4.16 | amino-acid n-acetyltransferase deficiency |
34510628 |
Non-coding sequence variants define a novel regulatory element in the first intron of the N-acetylglutamate synthase gene. |
causal interaction
therapeutic application
unassigned |
1
3
0 |
